The BioTherapeutic Unit (BTU) is embedded in the divisions of Molecular Oncology & Immunology and Hospital Pharmacy at the NKI and is responsible for the development and production of the biotherapeutic products, mainly used for experimental immunotherapy.
Four dedicated, fully equipped and state-of-art class A/B cleanrooms are available for production activities under full Good Manufacturing Practice (GMP). We are particularly experienced in the production of T cell products and plasmid DNA, but we are also interested to further expand the current product portfolio.
